GloGen Clinical Research Reports USFDA EIR with ‘Closed’ Status Following February Inspection
GloGen Clinical Research Pvt. Ltd. has received the Establishment Inspection Report (EIR) from USFDA, with the determination of “Closed”, auditorium conducted on 09th -13th...
Glenmark Pharmaceuticals Wins U.S. FDA Nod for Generic Progesterone Fertility Therapy
Glenmark Pharmaceuticals has received final approval from the U.S. Food and Drug Administration for its Progesterone Vaginal Inserts, 100 mg, marking a meaningful step forward in expanding...
Dr. Reddy’s Makes History with Health Canada Approval of World’s First Generic Semaglutide Injection in a G7 Market
Dr. Reddy’s Laboratories Ltd.a leading global pharmaceutical company, is pleased to announce it has received a Notice of Compliance (NOC) from Health Canada for...
Union Health Minister J. P. Nadda Reviews NIPER Mohali’s Innovation Pipeline, Inaugurates Medicinal Succulents Garden
Union Minister for Health and Family Welfare and Chemicals & Fertilizers, Shri J. P. Nadda, visited the National Institute of Pharmaceutical Education and Research...
Novartis Receives European Commission Approval for Rhapsido®, the First Oral Targeted Therapy for Chronic Spontaneous Urticaria
Novartis has officially received European Commission (EC) approval for Rhapsido® (remibrutinib), marking a historic shift in the management of chronic spontaneous urticaria (CSU). Rhapsido...
A Global Pediatric Milestone: WHO Pre qualifies First Malaria Treatment for Newborns and Young Infants
In a landmark step for global child health, the World Health Organization (WHO) has prequalified the world’s first malaria treatment specifically designed for newborns...